Actos Bladder Cancer Risks Confirmed by the Canadian Medical Association
07/06/2012

National Actos lawyers highlight the findings of a new study that confirms the link of the diabetes drug Actos to bladder cancer.

Online PR News – 06-July-2012 – Chicago, IL – TorHoerman Law, LLC, leaders in the Chicago Actos litigation, highlights the results from a new study that confirms the link of the diabetes drug Actos to bladder cancer. After combining the findings of five smaller studies, scientists at the Canadian Medical Association state:

"Our results suggest an association between pioglitazone (Actos) use and bladder cancer in adults with type 2 diabetes"

Since the filing of the first lawsuits in Chicago against Takeda International, a Japanese corporation with its US headquarters in Illinois, TorHoerman Law, LLC, a national law firm, has been at the lead of the Chicago litigation and continues to keep clients and consumers informed of the dangers of Actos.

The FDA issued a warning last June regarding the increased risk of bladder cancer followed by a few European markets removing Actos and the filing of multiple lawsuits as a result of the bladder cancer risk. According to Eric Terry of TorHoerman Law:

"Takeda can’t avoid the consistent findings of the bladder cancer risk associated with Actos. We plan to investigate all of these studies and we look forward to Takeda’s responses."

It should be noted that Actos is not the first type 2 diabetes drug to come under scrutiny. In fact, Actos is the last of the type 2 diabetes drugs belonging to the drug family thiazolidinedione (TZD) available in the U.S. without restriction. The other two TZDs left the US market as follows:

▪ Rezulin (troglitazone) - withdrawn from the U.S. market in 2000 as a result of an increased risk of liver damage;
▪ Avandia (rosiglitazone) - limited in its availability in the U.S. market in 2011 as a result of an increased risk of heart attack, cardiovascular disease, stroke and death.

Today’s diabetic must be informed. If you are a diabetic, your focus should remain on your health. It is always advisable to discuss any risks and concerns with your physician. If you or a loved one has bladder cancer and has taken Actos, then it may be time to discuss your options with a lawyer as well.

TorHoerman Law is a national drug, medical device and toxic tort litigation firm. Representing clients in 50 states, we are not afraid to take on the largest companies when they put profits ahead of safety.

visit our website